RODIN THERAPEUTICS
Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS function, privileged access to Proteros' best-in-class structural biology capabilities, and a team with deep CNS drug development and company formation experience. Rodin secured financing from Atlas Venture and Johnson & Johnson Development Corporation (JJDC).
RODIN THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rodintherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
6175882600
Email Addresses:
[email protected]
Total Funding:
57.2 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail ReCAPTCHA Amazon Route 53 Gravity Forms Mimecast Rackspace
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Third Point Ventures
Third Point Ventures investment in Series C - Rodin Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - Rodin Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series C - Rodin Therapeutics
Atlas Venture
Atlas Venture investment in Series C - Rodin Therapeutics
GV
GV investment in Series C - Rodin Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Rodin Therapeutics
Biogen Idec
Biogen Idec investment in Series B - Rodin Therapeutics
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series A - Rodin Therapeutics
Atlas Venture
Atlas Venture investment in Series A - Rodin Therapeutics
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Seed Round - Rodin Therapeutics
Official Site Inspections
http://www.rodintherapeutics.com
- Host name: 174.143.31.7
- IP address: 174.143.31.7
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
